Evercore ISI analyst Liisa Bayko maintained a Buy rating on Vertex Pharmaceuticals (VRTX – Research Report) on January 31 and set a price target of $515.00. The company’s shares closed last ...
In a report released on January 31, Jesalyn Wong from Evercore ISI maintained a Buy rating on Deckers Outdoor (DECK – Research Report), with a price target of $235.00. The company’s shares ...
After hours: February 3 at 6:19:07 p.m. EST ...
Q2 2025 Earnings Conference Call February 3, 2025 5:00 PM ETCompany ParticipantsLisah Burhan - Vice President, ...
Doximity Inc. (NYSE:DOCS) reported robust financial results for Q3 FY2025, significantly exceeding expectations with an EPS ...
Clorox Co (CLX), with a market capitalization of $19.8 billion, reported its second-quarter 2024 earnings, surpassing analyst expectations with an earnings per share (EPS) of $1.55, compared to the ...
Royalty-free licenses let you pay once to use copyrighted images and video clips in personal and commercial projects on an ongoing basis without requiring additional payments each time you use that ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback